Income Tax Expense (Benefit) of Co-Diagnostics, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Co-Diagnostics, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $1,166,593, a 5358% decline year-over-year.
  • Co-Diagnostics, Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $1,150,437, a 130% decline year-over-year.
  • Co-Diagnostics, Inc. annual Income Tax Expense (Benefit) for 2024 was $57,368.
  • Co-Diagnostics, Inc. annual Income Tax Expense (Benefit) for 2023 was $2,777,691, a 40% increase from 2022.
  • Co-Diagnostics, Inc. annual Income Tax Expense (Benefit) for 2022 was $4,608,985, a 151% decline from 2021.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Co-Diagnostics, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,150,437 $1,166,593 -$1,188,782 -5358% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $38,345 $12,327 -$8,263 -40% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $46,608 $12,004 -$10,760 -47% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $57,368 $8,175 -$3,842,196 -100% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $3,899,564 $22,189 +$2,135,770 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $1,763,794 $20,590 +$2,258,910 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $495,116 $22,764 +$2,282,575 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $2,777,691 $3,834,021 +$6,972,948 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $9,750,639 $2,113,581 +$1,057 +0.05% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $9,751,696 $2,238,320 -$1,496,813 -202% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $8,254,883 $2,259,811 -$3,645,898 -263% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $4,608,985 $3,138,927 -$5,884,848 -214% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $1,275,863 $2,114,638 -$4,215,232 -201% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $5,491,095 $741,507 -$2,886,583 -135% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $8,377,678 $1,386,087 -$599,553 -30% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $8,977,231 $2,745,921 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $2,100,594 +$5,015,375 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $2,145,076 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $1,985,640 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 $2,914,781 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3

Co-Diagnostics, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $57,368 +$2,835,059 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $2,777,691 +$1,831,294 +40% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $4,608,985 -$13,586,216 -151% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $8,977,231 +$8,886,695 +9816% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $90,536 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.